Echo IQ Limited (EIQ.AX)
Echo IQ Limited operates in the Other Precious Metals industry of the Basic Materials sector, headquartered in Sydney, NSW, AU. The stock last traded at $1.66, up 5.06% on the session, giving a market capitalisation of $1.23B. Its beta of 0.14 implies it has historically moved less than the broad market.
Echo IQ Limited engages in the provision of artificial intelligence (AI) diagnostics tool that enhance the diagnosis of structural heart disease in Australia. It offers EchoSolv, provides an AI-powered risk assessment of structural heart disease, including aortic stenosis, diastolic dysfunction, and heart failure. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Claremont, Australia.
Echo IQ Limited is most often compared with the following Basic Materials names: